SCHEMBL9402504

SCHEMBL9402504

CCCCc1nnc([S+]([O-])Cc2ccc(OC)cc2)n1Cc1ccc(NC(=O)c2ccccc2-c2nnn[nH]2)cc1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9402208 0.92 — —
SCHEMBL9402284 0.86 AGTR1 (0.44) —
SCHEMBL9402277 0.85 — —
SCHEMBL9402484 0.83 — —
SCHEMBL9402243 0.78 — —
SCHEMBL9402346 0.78 — —
SCHEMBL9402215 0.77 AGTR1 (0.45) —
SCHEMBL9402359 0.77 — —
SCHEMBL9402348 0.77 — —
SCHEMBL9402493 0.77 — —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5336778-A Substituted triazoles as angiotensin II antagonists MERCK & CO., INC. (US) 1994-08-09 — — US disclosed
Send feedback